You searched for metabolic diseases - Page 22 of 62

In Depth 28 Nov 2017

Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?

Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix each of them. Here’s a review of biotech’s progress. Biotech is arguably built on…

November 28, 2017 - 8 minutesmins - By Evelyn Warner

News and Trends 21 Jul 2022

Almirall launches new call to find innovative therapies for skin diseases

A new call for new therapies to treat skin diseases has been launched by global Spanish-based biopharmaceutical company, Almirall, S.A. This is the seventh call through AlmirallShare – an open…

July 21, 2022 - 3 minutesmins - By Liza Laws

More News! 16 Apr 2018

Epitopes Come to the Rescue for One of the Most Common Autoimmune Diseases

The British-Belgian biotech Apitope has obtained positive Phase I results for its first-in-class treatment for Graves’ disease, one of the most common autoimmune diseases. Apitope has obtained positive clinical results…

April 16, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 22 Sep 2022

New phase 1 biomarker results reported by Glyscend Therapeutics for diabetes drug

…GLY-200 for the treatment of T2D and has initiated a phase 2 clinical trial in patients with the condition. Glyscend says that metabolic surgery is a highly effective but invasive…

September 22, 2022 - 4 minutesmins - By Liza Laws

Interview 11 Jul 2017

The Advantage for the First Mover in NASH is Limited, says Genfit

…enough,” said Hum. “As we see in other metabolic diseases, there’s a small number of patients in other metabolic diseases who are able to maintain that lifestyle.” “The point is…

July 11, 2017 - 4 minutesmins - By Evelyn Warner

Startup Scout 11 May 2018

This Oxford Biotech is Using DNA to Find New Peptide Drugs

…variety of indications, from oncology and autoimmune diseases to metabolic, cardiovascular and infectious diseases seems exciting. However, there are not many peptide drugs on the market. It will be interesting…

May 11, 2018 - 2 minutesmins - By Alexander Burik

Best in Biotech 6 Jun 2024

Eight biotech companies advancing the field of siRNA

…thereby preventing them from being translated into proteins. This specific mechanism has the potential to treat a wide range of diseases, from genetic disorders and cancers to viral infections. Unlike…

June 6, 2024 - 11 minutesmins - By Jules Adam

In Depth 14 Apr 2025

Metabolomics: The study of biology’s dark matter

…confined to a set of monomers, instead, they can be any small molecule resulting from metabolic reactions. “If genomics, transcriptomics, and proteomics are Lego kits, with metabolites you are now…

April 14, 2025 - 7 minutesmins - By Jules Adam

Best in Biotech 17 Sep 2024

Estonia: Seven biotech companies to reckon with

…potential of N6-methyladenosine (m6A), a chemical modification found in RNA that is implicated in various neurodegenerative and neuropsychiatric diseases, as well as cancer. Chemestmed’s work in epitranscriptomics aims to regulate…

September 17, 2024 - 7 minutesmins - By Jules Adam

News and Trends 15 Mar 2023

Cambrian Bio to boost aging pipeline with Amplifier Therapeutics launch

…AMPK decreases as we age. Given the central role of AMPK in whole body energy regulation, AMPK activators have broad potential therapeutic applications in metabolic conditions, cardiovascular diseases, kidney diseases,…

March 15, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 15 Nov 2022

Jnana Therapeutics raises $107M for PKU program and announces new Roche partnership

Jnana Therapeutics has entered into a second collaboration and license agreement with Roche for the discovery of small molecule drugs for the treatment of cancer, immune-mediated and neurological diseases. The…

November 15, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 27 May 2025

Interleukin therapeutics: 9 companies to follow in 2025

…interleukin as treatments for cancer, autoimmune conditions, and inflammatory diseases. But while some interleukin-based drugs have reached the market, many early attempts were held back by toxicity and a lack…

May 27, 2025 - 12 minutesmins - By Jules Adam

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?

Almirall launches new call to find innovative therapies for skin diseases

Epitopes Come to the Rescue for One of the Most Common Autoimmune Diseases

New phase 1 biomarker results reported by Glyscend Therapeutics for diabetes drug

The Advantage for the First Mover in NASH is Limited, says Genfit

This Oxford Biotech is Using DNA to Find New Peptide Drugs

Eight biotech companies advancing the field of siRNA

Metabolomics: The study of biology’s dark matter

Estonia: Seven biotech companies to reckon with

Cambrian Bio to boost aging pipeline with Amplifier Therapeutics launch

Jnana Therapeutics raises $107M for PKU program and announces new Roche partnership

Interleukin therapeutics: 9 companies to follow in 2025

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!